Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,2,4-triazole, Potassium Salt
1. 1h-1,2,4-triazole
2. 288-88-0
3. 4h-1,2,4-triazole
4. Pyrrodiazole
5. S-triazole
6. 1,2,4-1h-triazole
7. 63598-71-0
8. Mfcd00005228
9. Nsc 83128
10. Dtxsid6027131
11. Peptone, Bacteriological
12. 1h-[1,2,4]triazole
13. 10ms0y1rdi
14. Chebi:46077
15. Nsc-83128
16. (1,2,4)-triazole
17. [1,2,4]-triazole
18. 736917-78-5
19. 1,2,4 Triazole
20. 1h-1,2,4-triazol
21. 1,2,4-triazol
22. 4h-1,2,4-triazole (van)
23. Einecs 206-022-9
24. Unii-10ms0y1rdi
25. Ai3-51031
26. Hsdb 7860
27. 1,4-triazole
28. 1,2,4triazole
29. 1,3,4-triazole
30. 1h-1,4-triazole
31. 4h-1,4-triazole
32. [1,2,4]triazole
33. 1,2, 4-triazole
34. 1,2,4,-triazole
35. [1,2,4]triazol
36. [1.2.4]-triazole
37. 1, 2, 4 Triazole
38. [1,2,4]-triazol
39. 1,2,4-1h Triazole
40. Dsstox_cid_7131
41. Ec 206-022-9
42. 4h-[1,2,4]triazole
43. Dsstox_rid_78318
44. Dsstox_gsid_27131
45. 1h-[1,2,4]-triazole
46. Chembl15571
47. 1,2,4-triazole, 98%
48. Niosh/xz3807000
49. Chebi:35550
50. Efinaconazole Metabolite H1
51. Amy40414
52. Bcp20885
53. Cs-d1150
54. Nsc83128
55. Triazole, 1h,1,2,4-
56. Zinc5943507
57. Tox21_300113
58. Cga-71019
59. Mfcd01941334
60. Stk366100
61. 1,2,4-triazole, Analytical Standard
62. 1h-1,2,4-triazole [mi]
63. Akos000120326
64. Akos000269054
65. 1h-1,2,4-triazole [hsdb]
66. Db03594
67. Ps-9377
68. Ncgc00247903-01
69. Ncgc00254087-01
70. Bp-12667
71. Cas-288-88-0
72. Sy001414
73. Db-002017
74. Bb 0267986
75. Cs-0368547
76. Ft-0607865
77. T0340
78. Xz38070000
79. 88t880
80. E76126
81. T-6200
82. 1,2,4-triazole, Vetec(tm) Reagent Grade, 98%
83. A819652
84. Q161300
85. F1918-0085
86. Z1245636363
| Molecular Weight | 69.07 g/mol |
|---|---|
| Molecular Formula | C2H3N3 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 69.032697108 g/mol |
| Monoisotopic Mass | 69.032697108 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 5 |
| Formal Charge | 0 |
| Complexity | 28.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
After a single oral administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 100% of the (14)C activity was absorbed from the digestive tract.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
8 hr after a single iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx 50% of the applied radioactivity was detectable in the body of the animals (gastrointestinal tract not considered). 3 days after the application approx 1.5% of the applied activity could be found, and after 6 days the (14)C-activity was no longer measurable (detection limit 0.3%).
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
Following a single oral or iv administration of 1 mg/kg bw (test substance (14)C-labeled) to male rats (strain not given), approx. 0.1% of the (14)C-activity was exhaled within 30 hr.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
1H-1,2,4-Triazole (14)C-labeled was administered to male rats orally (dose: 1 mg/kg bw) or iv (doses: 0.1, 1, 10, 100 mg/kg bw). Within 48 hr after the single application 92-94% of the (14)C-activity was excreted with the urine and 3-5% with the feces, regardless whether the substance was applied orally or iv.
European Commission, ESIS; IUCLID Dataset, 1,2,4-Triazole (288-88-0) p.17 (2000 CD-ROM edition). Available from, as of September 23, 2010: https://esis.jrc.ec.europa.eu/
For more Absorption, Distribution and Excretion (Complete) data for 1H-1,2,4-Triazole (6 total), please visit the HSDB record page.
ABOUT THIS PAGE
A CAS-288-88-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-288-88-0, including repackagers and relabelers. The FDA regulates CAS-288-88-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-288-88-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-288-88-0 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-288-88-0 supplier is an individual or a company that provides CAS-288-88-0 active pharmaceutical ingredient (API) or CAS-288-88-0 finished formulations upon request. The CAS-288-88-0 suppliers may include CAS-288-88-0 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-288-88-0 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-288-88-0 CEP of the European Pharmacopoeia monograph is often referred to as a CAS-288-88-0 Certificate of Suitability (COS). The purpose of a CAS-288-88-0 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CAS-288-88-0 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CAS-288-88-0 to their clients by showing that a CAS-288-88-0 CEP has been issued for it. The manufacturer submits a CAS-288-88-0 CEP (COS) as part of the market authorization procedure, and it takes on the role of a CAS-288-88-0 CEP holder for the record. Additionally, the data presented in the CAS-288-88-0 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CAS-288-88-0 DMF.
A CAS-288-88-0 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CAS-288-88-0 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CAS-288-88-0 suppliers with CEP (COS) on PharmaCompass.
CAS-288-88-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-288-88-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-288-88-0 GMP manufacturer or CAS-288-88-0 GMP API supplier for your needs.
A CAS-288-88-0 CoA (Certificate of Analysis) is a formal document that attests to CAS-288-88-0's compliance with CAS-288-88-0 specifications and serves as a tool for batch-level quality control.
CAS-288-88-0 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-288-88-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-288-88-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-288-88-0 EP), CAS-288-88-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-288-88-0 USP).
LOOKING FOR A SUPPLIER?
